FDA Places CT1812, Potential Disease-Modifying Alzheimer’s Treatment, on Fast Track Alzheimer’s Today By John Harbison|2017-10-18T12:33:08-08:00October 18, 2017|Tech Coast Angels Portfolio Companies in the Press|Comments Off on FDA Places CT1812, Potential Disease-Modifying Alzheimer’s Treatment, on Fast Track Share This Story, Choose Your Platform! FacebookTwitterRedditLinkedInWhatsAppTumblrPinterestVkXingEmail About the Author: John Harbison Related Posts